MCK vs PROF · P/E 20, rev $403.43B vs rev $10.7M
McKesson Corporation (MCK) versus Profound Medical Corp (PROF) — a side-by-side from cached financials, not a winner call.
McKesson Corporation (MCK) is a medical distribution company listed on NYSE.
Profound Medical Corp (PROF) is a medical devices company listed on NASDAQ.
Latest reported MCK revenue for 2026-03-31 was $403.43B. Net income was $4.76B. Revenue was up 12.4% from 2025-03-31 to 2026-03-31. MCK currently screens at market cap $91.30B and trailing P/E 20.3.
Latest reported PROF revenue for 2024-12-31 was $10.7M. Net income was -$27.8M. Revenue was up 48.4% from 2023-12-31 to 2024-12-31. PROF currently screens at market cap $238.7M.
MCK currently screens at market cap $91.30B and trailing P/E 20.3. PROF currently screens at market cap $238.7M.
Not investment advice. Open the MCK and PROF stock pages for the full models.
Not investment advice.